Identification of LINC02310 as an enhancer in lung adenocarcinoma and investigation of its regulatory network via comprehensive analyses
- PMID: 33308216
- PMCID: PMC7731780
- DOI: 10.1186/s12920-020-00834-6
Identification of LINC02310 as an enhancer in lung adenocarcinoma and investigation of its regulatory network via comprehensive analyses
Abstract
Background: Lung adenocarcinoma (LADC) is a major subtype of non-small cell lung cancer and has one of the highest mortality rates. An increasing number of long non-coding RNAs (LncRNAs) were reported to be associated with the occurrence and progression of LADC. Thus, it is necessary and reasonable to find new prognostic biomarkers for LADC among LncRNAs.
Methods: Differential expression analysis, survival analysis, PCR experiments and clinical feature analysis were performed to screen out the LncRNA which was significantly related to LADC. Its role in LADC was verified by CCK-8 assay and colony. Furthermore, competing endogenous RNA (ceRNA) regulatory network construction, enrichment analysis and protein-protein interaction (PPI) network construction were performed to investigate the downstream regulatory network of the selected LncRNA.
Results: A total of 2431 differentially expressed LncRNAs (DELncRNAs) and 2227 differentially expressed mRNAs (DEmRNAs) were from The Cancer Genome Atlas database. Survival analysis results indicated that lnc-YARS2-5, lnc-NPR3-2 and LINC02310 were significantly related to overall survival. Their overexpression indicated poor prognostic. PCR experiments and clinical feature analysis suggested that LINC02310 was significantly correlated with TNM-stage and T-stage. CCK-8 assay and colony formation assay demonstrated that LINC02310 acted as an enhancer in LADC. In addition, 3 targeted miRNAs of LINC02310 and 414 downstream DEmRNAs were predicted. The downstream DEmRNAs were then enriched in 405 Gene Ontology terms and 11 Kyoto Encyclopedia of Genes and Genomes pathways, which revealed their potential functions and mechanisms. The PPI network showed the interactions among the downstream DEmRNAs.
Conclusions: This study verified LINC02310 as an enhancer in LADC and performed comprehensive analyses on its downstream regulatory network, which might benefit LADC prognoses and therapies.
Keywords: LADC; LncRNA; PPI; TCGA; ceRNA regulatory network.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures










Similar articles
-
A comprehensive study of construction and analysis of competitive endogenous RNA networks in lung adenocarcinoma.Biochim Biophys Acta Proteins Proteom. 2020 Aug;1868(8):140444. doi: 10.1016/j.bbapap.2020.140444. Epub 2020 May 11. Biochim Biophys Acta Proteins Proteom. 2020. PMID: 32423886
-
Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.Cancer Biomark. 2020;29(3):399-416. doi: 10.3233/CBM-200133. Cancer Biomark. 2020. PMID: 32741804
-
Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.Int J Med Sci. 2020 Sep 1;17(16):2427-2439. doi: 10.7150/ijms.49053. eCollection 2020. Int J Med Sci. 2020. PMID: 33029085 Free PMC article.
-
Reconstruction and Analysis of the Differentially Expressed IncRNA-miRNA-mRNA Network Based on Competitive Endogenous RNA in Hepatocellular Carcinoma.Crit Rev Eukaryot Gene Expr. 2019;29(6):539-549. doi: 10.1615/CritRevEukaryotGeneExpr.2019028740. Crit Rev Eukaryot Gene Expr. 2019. PMID: 32422009 Review.
-
Identification of MFI2-AS1, a Novel Pivotal lncRNA for Prognosis of Stage III/IV Colorectal Cancer.Dig Dis Sci. 2020 Dec;65(12):3538-3550. doi: 10.1007/s10620-020-06064-1. Epub 2020 Jan 20. Dig Dis Sci. 2020. PMID: 31960204 Review.
Cited by
-
Circular RNA-microRNA-mRNA network identified circ_0007618 and circ_0029426 as new valuable biomarkers for lung adenocarcinoma.Bioengineered. 2022 Mar;13(3):6258-6271. doi: 10.1080/21655979.2022.2027180. Bioengineered. 2022. PMID: 35212617 Free PMC article.
-
Web tools to perform long non-coding RNAs analysis in oncology research.Database (Oxford). 2021 Jul 23;2021:baab047. doi: 10.1093/database/baab047. Database (Oxford). 2021. PMID: 34296748 Free PMC article. Review.
-
Tumor necrosis factor-related lncRNAs predict prognosis and immunotherapy response for patients with lung adenocarcinoma.J Thorac Dis. 2023 Mar 31;15(3):1373-1386. doi: 10.21037/jtd-23-184. Epub 2023 Mar 27. J Thorac Dis. 2023. PMID: 37065578 Free PMC article.
-
Exploring the Prognosis-Related Genetic Variation in Gastric Cancer Based on mGWAS.Int J Mol Sci. 2023 Oct 17;24(20):15259. doi: 10.3390/ijms242015259. Int J Mol Sci. 2023. PMID: 37894938 Free PMC article.
-
Prognostic value and immune landscapes of anoikis-associated lncRNAs in lung adenocarcinoma.Aging (Albany NY). 2024 Feb 5;16(3):2273-2298. doi: 10.18632/aging.205481. Epub 2024 Feb 5. Aging (Albany NY). 2024. PMID: 38319706 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical